Immuneering reports Q1 2026 financial results and clinical updates
Go back to Immuneering reports Q1 2026 financial results and clinical updates| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 4.04 -0.03 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.07 | 52 Week High | $0.04 | |||
| Open | $4.07 | 52 Week Low | $0.00 | |||
| Day High | $4.12 | P/E | N/A | |||
| Day Low | $4.02 | EPS | $-0.09 | |||
| Volume | 482,714 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 39.66 +0.13 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.53 | 52 Week High | $66.55 | |||
| Open | $39.44 | 52 Week Low | $37.82 | |||
| Day High | $40.03 | P/E | N/A | |||
| Day Low | $39.27 | EPS | $0.00 | |||
| Volume | 4,147,861 | |||||



